Bortezomib recalls

The FDA has published 3 recalls involving Bortezomib since 2019. The latest was reported on 15 Jul 2026. Most were for sterility. Reliance Life Sciences Private has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2019

Last 12 months1reported

Class I00% of total

Ongoing1latest 15 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 1Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why bortezomib is recalled

Sterility267%
Potency & Assay133%

Companies

By year

2026133%
2022133%
2019133%

Ongoing bortezomib recalls

1 active

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Bortezomib for Injection 3.5mg/Vial per Single-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide

All bortezomib recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Bortezomib for Injection 3.5mg/Vial per Single-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
2 Mar 2022Drug	CLASS III	Bortezomib, 3.5 mg/vial, Single-Dose Vial recalled	Dr. Reddy's Laboratories	Potency & Assay	Nationwide
21 Aug 2019Drug	CLASS II	Bortezomib 2.5 mg / SQ Syringe recalled by Infusion Options	Infusion Options	Sterility	NY

Should you stop taking Bortezomib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.